Analyst Ratings for Oncternal Therapeutics (ONCT) [Buys]
ONCT Rating Summary
ONCT Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$15.00 (+69.3%)
* Over Last 12-Mos
Rating Score: 7.1 / 10 Percentile Rank: 77%
Rating Score: 7.1 / 10 Percentile Rank: 77%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
12/4/2023 | Brookline Capital Markets | Kemp Dolliver | Upgrade | Buy (Hold) |
2.00 (N/A) |
0.34 (8.86) |
2505.88% | Details |
9/18/2023 | H.C. Wainwright » Updated 4/15/2024 |
Raghuram Selvaraju | Upgrade | Buy (Neutral) |
28.00 (30.00) |
0.35 (8.86) |
2431.43% | Details |